39 related articles for article (PubMed ID: 16266928)
1. Antibody therapy of non-Hodgkin's B-cell lymphoma.
Chinn P; Braslawsky G; White C; Hanna N
Cancer Immunol Immunother; 2003 May; 52(5):257-80. PubMed ID: 12700943
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?
Mormile I; Granata F; Punziano A; de Paulis A; Rossi FW
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535377
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large cell lymphoma presenting as a sacral mass and lupus anticoagulant.
Ediriwickrema LS; Zaheer W
Yale J Biol Med; 2011 Dec; 84(4):433-8. PubMed ID: 22180680
[TBL] [Abstract][Full Text] [Related]
4. Use of rituximab in the antiphospholipid syndrome.
Kumar D; Roubey RA
Curr Rheumatol Rep; 2010 Feb; 12(1):40-4. PubMed ID: 20425532
[TBL] [Abstract][Full Text] [Related]
5. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Sieper J; Emery P; Keystone EC; Schiff MH; Mease P; van Riel PL; Fleischmann R; Weisman MH; Weinblatt ME
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii2-22. PubMed ID: 17934088
[No Abstract] [Full Text] [Related]
6. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.
Erre GL; Pardini S; Faedda R; Passiu G
Lupus; 2008 Jan; 17(1):50-5. PubMed ID: 18089684
[TBL] [Abstract][Full Text] [Related]
7. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
10. Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Veneri D; Ambrosetti A; Franchini M; Mosna F; Poli G; Pizzolo G
Haematologica; 2005 Nov; 90 Suppl():ECR37. PubMed ID: 16266928
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
